authors
- Lalani, Aly-Khan
- Lalani, A
- Swaminath, Anand
- Pond, Gregory
- Morgan, SC
- Azad, A
- Chu, W
- Winquist, E
- Kapoor, A
- Bonert, Michael
- Bramson, Jonathan
- Surette, Michael
- Canil, CM
- Siva, S
- Bjarnason, GA
- Levine, Mark Norman
- Wright, James
- Hotte, Sebastien
Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK)
Conferences
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- February 16, 2022
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal